This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Boston University, University of Toronto. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 836 
1 out of 533 
Years Active: 2022
Title: Luke Whitesell: Innovator in Hsp90 Inhibitors
Introduction
Luke Whitesell is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of Hsp90 inhibitors. His work focuses on compounds that have the potential to treat diseases related to Hsp90.
Latest Patents
Whitesell holds a patent for "Hsp90 inhibitors and uses thereof." This patent describes the design and synthesis of resorcylate aminopyrazole compounds. These compounds exhibit broad, potent, and fungal-selective Hsp90 inhibitory activity. They also have applications in treating various Hsp90-related diseases.
Career Highlights
Throughout his career, Luke Whitesell has worked with prestigious institutions such as Boston University and the University of Toronto. His research has contributed to advancements in understanding and utilizing Hsp90 inhibitors in therapeutic contexts.
Collaborations
Some of his notable coworkers include Lauren E. Brown and David S. Huang. Their collaborative efforts have furthered research in the field of Hsp90 inhibitors.
Conclusion
Luke Whitesell's innovative work in the development of Hsp90 inhibitors showcases his commitment to advancing medical science. His contributions are significant in the ongoing quest to find effective treatments for Hsp90-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile